Summit Trail Advisors’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.73M | Buy |
+34,723
| New | +$3.73M | 0.06% | 154 |
|
|
2024
Q4 | – | Sell |
-12,342
| Closed | -$1.03M | – | 454 |
|
|
2024
Q3 | $1.03M | Buy |
12,342
+1,575
| +15% | +$132K | 0.03% | 255 |
|
|
2024
Q2 | $829K | Buy |
10,767
+1,403
| +15% | +$108K | 0.02% | 270 |
|
|
2024
Q1 | $641K | Buy |
9,364
+884
| +10% | +$60.5K | 0.02% | 290 |
|
|
2023
Q4 | $490K | Sell |
8,480
-1,265
| -13% | -$73.1K | 0.02% | 283 |
|
|
2023
Q3 | $515K | Buy |
9,745
+1,714
| +21% | +$90.5K | 0.02% | 266 |
|
|
2023
Q2 | $434K | Buy |
8,031
+2,816
| +54% | +$152K | 0.02% | 293 |
|
|
2023
Q1 | $261K | Buy |
+5,215
| New | +$261K | 0.01% | 344 |
|
|
2018
Q1 | – | Sell |
-4,930
| Closed | -$135K | – | 595 |
|
|
2017
Q4 | $135K | Buy |
+4,930
| New | +$135K | 0.02% | 544 |
|